Announcements
FDA Clearance of IND Application for A Phase 1 Study of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)
Date of occurrence of the event: January 17, 2018 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): Head office Reciprocal shareholding ratios: …
Shilin District Court deny OBI’s request to submit the case for trial
Defendant: Reporter Pei amongst the other six reporters Name of the legal agency or court: Taiwan Shilin District Court Reference/case numbers of relevant documents: 2017 Sheng Pan Zi, No. 72 …
OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities
Date: January 16, 2018 Date of the event: Jan 16, 2018 Time: 14:00:00 (Taiwan Time) Location：Courtyard Marriott Taipei Summary: OBI Pharma Inc. to attend the investor conference on new drug …
Capital increase for new shares to transfer to AP Biosciences, Inc.
Type of merger/acquisition (e.g. merger, consolidation, spin-off,acquisition, or receiving assignment of shares): Receiving assignment of shares Date of occurrence of the event: Dec 29, 2017 Names of companies participating in …
OBI Pharma Inc. to attend the 36th J.P. Morgan Annual Healthcare Conference
Date: Jan 9, 2018 Date of the event: Jan 09–Jan 11, 2018 Time: 01:00:00 EST Location: Westin St. Francis Hotel, San Francisco, CA USA Summary: OBI Pharma Inc. to attend …
OBI Pharma Inc. to attend Citi’s 2017 Global Healthcare Conference
Date: Dec 06, 2017 Date of the event: Dec 06–Dec 07, 2017 Time: 21:30:00 EST Location：The Lotte New York Palace, New York USA Summary: OBI Pharma Inc. to attend the …
OBI Pharma Inc. to attend the 2017 Asia Pacific Healthcare Forum, hosted by Goldman Sachs
Date of the event: Nov 29–Nov 30, 2017 Time: 09:00:00 CST Location: Jw Marriott Hotel Hong Kong Level 3 Ballroom Summary: OBI Pharma Inc. to attend the 2017 Asia Pacific …
SFIPC and OBI jointly agreed to withdraw the proceedings on Civil case regarding the dismissal of the Chairman of the company.
Parties to the legal matter: Plaintiff: Securities and Futures Investors Protection Center (SFIPC) Defendant: OBI Pharma, Inc. and Dr. Michael N. Chang (Chairman) Name of the legal agency or court: …
OBI Plans to Issue New Shares in Exchange for the AP Biosciences, Inc. Shares Owned by AbProtix,Inc, Subject to Regulatory Approval
Please visit Investor Announcement page for more detail.
Announcement on Change of the Accounting Officer
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or internal audit officer): Accounting Officer Date of …